H. Lundbeck A/S:企業の戦略・SWOT・財務情報

◆英語タイトル:H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15504
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

H. Lundbeck A/S – Strategy, SWOT and Corporate Finance Report
Summary

H. Lundbeck A/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

H. Lundbeck A/S (Lundbeck or ‘the company’) is a specialty pharmaceutical company primarily focusing on brain diseases. The company’s products are focused on treating depression/anxiety, Alzheimer’s disease, schizophrenia, alcohol dependence, Parkinson’s disease, epilepsy (including lennox-gastaut syndrome), huntington’s disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension and bipolar disorders. Lundbeck’s brands include Abilify Maintena, Abixa, Azilect, Brintellix, Celexa and Cipralex. Lundbeck manages its manufacturing facilities in China, Italy, Denmark and France. The company sells its products to hospitals, pharmacies, and other distributors. The company is headquartered in Valby, Denmark.

Scope

- Detailed information on H. Lundbeck A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting H. Lundbeck A/S in the form of a SWOT analysis
- An in-depth view of the business model of H. Lundbeck A/S including a breakdown and examination of key business segments
- Intelligence on H. Lundbeck A/S’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about H. Lundbeck A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of H. Lundbeck A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess H. Lundbeck A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on H. Lundbeck A/S’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
H. Lundbeck A/S: Company Overview
H. Lundbeck A/S: Overview and Key Facts
H. Lundbeck A/S: Overview
H. Lundbeck A/S: Key Facts
H. Lundbeck A/S: Key Employees
H. Lundbeck A/S: Key Employee Biographies
H. Lundbeck A/S: Major Products and Services
H. Lundbeck A/S: Company History
H. Lundbeck A/S: Management Statement
H. Lundbeck A/S: Locations and Subsidiaries
H. Lundbeck A/S: Key Competitors
H. Lundbeck A/S: Company Analysis
H. Lundbeck A/S: Business Description
H. Lundbeck A/S: SWOT Analysis
H. Lundbeck A/S: SWOT Overview
H. Lundbeck A/S: Strengths
H. Lundbeck A/S: Weaknesses
H. Lundbeck A/S: Opportunities
H. Lundbeck A/S: Threats
H. Lundbeck A/S: Corporate Financial Deals Activity
H. Lundbeck A/S: Financial Deals Overview
H. Lundbeck A/S: Targets and Partners
H. Lundbeck A/S: Top Deals 2015 – 2019YTD*
H. Lundbeck A/S: Advisors
H. Lundbeck A/S: Top Legal Advisors
H. Lundbeck A/S: Mergers and Acquisitions
H. Lundbeck A/S: Partnership
H. Lundbeck A/S: Divestments
H. Lundbeck A/S: Recent Developments
H. Lundbeck A/S: News and Events Summary
H. Lundbeck A/S: Contracts
H. Lundbeck A/S: Corporate Governance
H. Lundbeck A/S: Financial Deals
H. Lundbeck A/S: Financial Performance
H. Lundbeck A/S: Market Developments
H. Lundbeck A/S: Regulatory and Legal Events
H. Lundbeck A/S: Research & Development
H. Lundbeck A/S: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: H. Lundbeck A/S: Key Facts
Table 2: H. Lundbeck A/S: Key Employees
Table 3: H. Lundbeck A/S: Company History
Table 4: H. Lundbeck A/S: Locations and Subsidiaries
Table 5: H. Lundbeck A/S: Key Competitors
Table 6: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
Table 7: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
Table 8: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
Table 10: H. Lundbeck A/S: Targets and Partners
Table 11: H. Lundbeck A/S: Top Deals 2015 - 2019YTD*
Table 12: H. Lundbeck A/S: Legal Advisor Ranking by Value (US$m)
Table 13: H. Lundbeck A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: H. Lundbeck A/S: M&A Activity by Geography (2015 - YTD*2019)
Table 15: H. Lundbeck A/S: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: H. Lundbeck A/S: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: H. Lundbeck A/S: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: H. Lundbeck A/S: News and Events Summary
Table 19: H. Lundbeck A/S: Contracts
Table 20: H. Lundbeck A/S: Corporate Governance
Table 21: H. Lundbeck A/S: Financial Deals
Table 22: H. Lundbeck A/S: Financial Performance
Table 23: H. Lundbeck A/S: Market Developments
Table 24: H. Lundbeck A/S: Regulatory and Legal Events
Table 25: H. Lundbeck A/S: Research & Development
Table 26: H. Lundbeck A/S: Strategy and Operations

List of Figures
Figure 1: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
Figure 3: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
Figure 5: H. Lundbeck A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: H. Lundbeck A/S: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: H. Lundbeck A/S: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 8: H. Lundbeck A/S: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 9: H. Lundbeck A/S: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[H. Lundbeck A/S:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, m …
  • NxStage Medical Inc (NXTM):企業の製品パイプライン分析2018
    Summary NxStage Medical Inc (NxStage) is a medical technology company that develops, manufactures and markets conventional dialysis machines. The company develops products for the treatment of end-stage renal disease and acute kidney failure. It provides products such as nxstage system one, cartridg …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Syndicate Bank Ltd (SYNDIBANK):企業の財務・戦略的SWOT分析
    Syndicate Bank Ltd (SYNDIBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Genzyme Corp:医療機器:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Swiss Re Group:企業のM&A・事業提携・投資動向
    Swiss Re Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Re Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • IP Group plc:企業のM&A・事業提携・投資動向
    IP Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IP Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Triumvira Immunologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Triumvira Immunologics Inc (Triumvira) is a biopharmaceutical company developing engineered T cell therapies for the treatment of multiple cancers. Its proprietary immuno-oncology platform T cell Antigen Coupler (TAC), enables natural T cell receptor to induce a controlled, tumor-specific re …
  • Telephonics Corp:企業の戦略的SWOT分析
    Telephonics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ANGLE Plc (AGL):医療機器:M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • O’Reilly Automotive, Inc.:企業の戦略・SWOT・財務情報
    O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary O'Reilly Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Florida Power & Light Co:発電所・企業SWOT分析
    Florida Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Martin Midstream Partners L.P.:企業の戦略・SWOT・財務情報
    Martin Midstream Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Martin Midstream Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Willis Lease Finance Corp (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tulmar Safety Systems Inc.:企業の戦略・SWOT・財務情報
    Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆